Fetal Medicine Foundation fetal and neonatal population weight charts

Journal article


Nicolaides, K. H., Wright, D., Syngelaki, A., Wright, A. and Akolekar, R. 2018. Fetal Medicine Foundation fetal and neonatal population weight charts. Ultrasound in Obstetrics and Gynecology. 52 (1), pp. 44-51. https://doi.org/10.1002/uog.19073
AuthorsNicolaides, K. H., Wright, D., Syngelaki, A., Wright, A. and Akolekar, R.
Abstract

Objective: To develop fetal and neonatal population weight charts. The rationale for this objective is that while reference ranges of estimated fetal weight (EFW) are representative of the whole population, the traditional approach of deriving birth-weight (BW) charts is misleading because a high proportion of babies born preterm arises from pathological pregnancies. We propose that the reference population for BW charts, as in the case of EFW charts, should be all babies at a given gestational age including those still in utero.

Patients: Two sources of data were used for this study and in both the inclusion criteria were singleton pregnancy, dating by fetal crown-rump length at 11+0 to 13+6 weeks’ gestation, ultrasonographic measurements of fetal head circumference (HC), abdominal circumference (AC) and femur length (FL), and livebirth of phenotypically normal neonate. Dataset 1, comprised a sample of 5,163 paired measurements of EFW and BW; the ultrasound scans were carried out at 22-43 weeks’ gestation and birth occurred within 2 days of the ultrasound examination. The EFW was derived from the measurements of HC, AC and FL using the formula reported by Hadlock et al. in 1985. Dataset 2, comprised a sample of 95,579 pregnancies with EFW obtained by routine ultrasonographic fetal biometry at 20+0 to 23+6 weeks’ gestation (n=45,034), or at 31+0 to 33+6 weeks (n=19,224) or at 35+0 to 36+6 weeks (n=31,321); for the purpose of this study we included data for only one of the three visits.

Methods: In the development of reference ranges of EFW and BW with gestational age the following assumptions were made: first, the EFW and BW have a common median, dependent on gestational age and second, deviations from the median occur in both EFW and BW and these deviations are correlated with different levels of spread for EFW and BW, dependent on gestational age. We adopted a Bayesian approach to inference combining information from the two datasets using Markov Chain Monte–Carlo sampling (MCMC). The fitted model assumed that the mean log transformed measurements of EFW and BW are
related to gestational age according to a cubic equation and that deviations about the mean follow a bivariate Gaussian distribution.

Results: In the case of EFW in dataset 2 there was a good distribution of values <3rd, <5th, <10th, >90th, >95th and >97th percentiles of the reference range of EFW with gestational age throughout the gestational age range of 20+0- 36+6 weeks. In the case of BW there was a good distribution of values only for the cases born at >39 weeks’ gestation. For preterm births, particularly at 27-36 weeks, the BW was below the 3rd, 5th and 10th percentiles in a very high proportion of cases and this was particularly marked for cases of iatrogenic birth. The incidence of SGA fetuses and neonates in the respective EFW and BW charts was higher in women of Black than White racial origin.

Conclusion: We established a BW chart for the population of all babies at a given gestational age, including those still in utero, which overcomes the problem of underestimation of growth restriction in preterm births. The BW and EFW charts have a common median but they differ in the levels of spread from the median.

KeywordsEstimated fetal weight; Birth weight; Fetal biometry; Reference range; Small for gestational age
Year2018
JournalUltrasound in Obstetrics and Gynecology
Journal citation52 (1), pp. 44-51
PublisherWiley
ISSN0960-7692
Digital Object Identifier (DOI)https://doi.org/10.1002/uog.19073
Official URLhttps://doi.org/10.1002/uog.19073
Publication dates
Online30 May 2018
Publication process dates
Accepted23 Apr 2018
Deposited28 May 2020
Accepted author manuscript
Permalink -

https://repository.canterbury.ac.uk/item/8v93x/fetal-medicine-foundation-fetal-and-neonatal-population-weight-charts

  • 146
    total views
  • 82
    total downloads
  • 0
    views this month
  • 0
    downloads this month

Export as

Related outputs

Maternal race and stillbirth: Cohort study and systematic review with meta-analysis.
Arechvo, Anastasija, Nikolaidi, Despoina A, Gil, M., Rolle, V., Syngelaki, A., Akolekar, Ranjit and Nicolaides, Kypros H. 2022. Maternal race and stillbirth: Cohort study and systematic review with meta-analysis. Journal of Clinical Medicine. 11 (12), p. 3452. https://doi.org/jcm11123452
Evaluation of the RCOG guideline for the prediction of neonates that are small for gestational age and comparison with the competing risks model
Papastefanou, I., Nowacka, U, Buerger, O, Akolekar, R, Wright, D and Nicolaides, KH 2021. Evaluation of the RCOG guideline for the prediction of neonates that are small for gestational age and comparison with the competing risks model. BJOG: An International Journal of Obstetrics & Gynaecology. 128 (13), pp. 2110-2115. https://doi.org/10.1111/1471-0528.16815
Predicting the risk to develop preeclampsia in the first trimester combining promoter variant -98A/C of LGALS13 (placental protein 13), Black ethnicity, previous preeclampsia, obesity, and maternal age
Madar-Shapiro, L., Karady, I., Trahtenherts, A., Syngelaki, A., Akolekar, R., Poon, L., Cohen, R., Sharabi-Nov, A., Huppertz, B., Sammar, M., Juhasz, K., Than, N.G., Papp, Z., Romero, R., Nicolaides, K.H. and Meiri, H. 2018. Predicting the risk to develop preeclampsia in the first trimester combining promoter variant -98A/C of LGALS13 (placental protein 13), Black ethnicity, previous preeclampsia, obesity, and maternal age. Fetal Diagnosis & Therapy. 43 (4), pp. 250-265. https://doi.org/10.1159/000477933
Risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review of the literature
Beta, J., Lesmes-Heredia, C., Bedetti, C. and Akolekar, R. 2018. Risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review of the literature. Minerva Ginecologica. 70 (2), pp. 215-219. https://doi.org/10.23736/S0026-4784.17.04178-8
Fetal major cardiac defects and placental dysfunction at 11-13 weeks' gestation
Fantasia, I., Kasapoglu, D., Kasapoglu, T., Syngelaki, A., Akolekar, R. and Nicolaides, K. H. 2018. Fetal major cardiac defects and placental dysfunction at 11-13 weeks' gestation. Ultrasound in Obstetrics and Gynecology. 51 (2), pp. 194-198. https://doi.org/10.1002/uog.18839
ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm
Allen, A., Poon, L. C., Rolnik, D. L., Tan, M. Y., Delgado, J. L., Tsokaki, T., Akolekar, R., Singh, M., Andrade, W., Efeturk, T., Jani, J. C., Plasencia, W., Papaioannou, G., Blazquez, A. R., Carbone, I. F., Wright, D. and Nicolaides, K. H. 2018. ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm. Ultrasound in Obstetrics and Gynecology. 51 (6), pp. 738-742. https://doi.org/10.1002/uog.19019
Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE
Tan, M. Y., Wright, D., Syngelaki, A., Akolekar, R., Cicero, S., Janga, D., Singh, M., Greco, E., Wright, A., Maclagan, K., Poon, L. C. and Nicolaides, K. H. 2018. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound in Obstetrics and Gynecology. 51 (6), pp. 743-750.
Ultrasonographic estimation of fetal weight: development of new model and assessment of performance of previous models
Hammami, A., Mazer Zumaeta, A., Syngelaki, A., Akolekar, R. and Nicolaides, K. H. 2018. Ultrasonographic estimation of fetal weight: development of new model and assessment of performance of previous models. Ultrasound in Obstetrics and Gynecology. 52 (1), pp. 35-43. https://doi.org/10.1002/uog.19066
Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation
Tan, M.Y., Syngelaki, A., Poon, L.C., Rolnik, D.L., O'Gorman, N., Delgado, J.L., Akolekar, R., Konstantinidou, L., Tsavdaridou, M., Galeva, S., Ajdacka, U., Molina, F.S., Persico, N., Jani, J.C., Plasencia, W., Greco, E., Papaioannou, G., Wright, A., Wright, D. and Nicolaides, K.H. 2018. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound in Obstetrics and Gynecology. 52 (2), pp. 186-195. https://doi.org/10.1002/uog.19112
Reference ranges for the size of the fetal cardiac outflow tracts from 13 to 36 weeks gestation: a single-center study of over 7000 cases
Vigneswaran, T.V., Akolekar, R., Syngelaki, A., Charakida, M., Allan, L.D., Nicolaides, K.H., Zidere, V. and Simpson, J.M. 2018. Reference ranges for the size of the fetal cardiac outflow tracts from 13 to 36 weeks gestation: a single-center study of over 7000 cases. Circulation Cardiovascular Imaging. 11 (7), p. e007575. https://doi.org/10.1161/CIRCIMAGING.118.007575
Comparison of screening for pre-eclampsia at 31-34 weeks' gestation by sFlt-1/PlGF ratio and a method combining maternal factors with sFlt-1 and PlGF
Tan, M.Y., Wright, D., Koutoulas, L., Akolekar, R. and Nicolaides, K.H. 2017. Comparison of screening for pre-eclampsia at 31-34 weeks' gestation by sFlt-1/PlGF ratio and a method combining maternal factors with sFlt-1 and PlGF. Ultrasound in Obstetrics and Gynecology. 49 (2), pp. 201-208. https://doi.org/10.1002/uog.17307
Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 30-34 weeks' gestation
Wright, D., Dragan, I., Syngelaki, A., Akolekar, R. and Nicolaides, K.H. 2017. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 30-34 weeks' gestation. Ultrasound in Obstetrics and Gynecology. 49 (2), pp. 194-200. https://doi.org/10.1002/uog.17309
Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation
O'Gorman, N., Wright, D., Poon, L.C., Rolnik, D.L., Syngelaki, A., Wright, A., Akolekar, R., Cicero, S., Janga, D., Jani, J., Molina, F.S., de Paco Matallana, C., Papantoniou, N., Persico, N., Plasencia, W., Singh, M. and Nicolaides, K.H. 2017. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound in Obstetrics and Gynecology. 49 (6), pp. 751-755. https://doi.org/10.1002/uog.17399
Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 35-37 weeks' gestation
Panaitescu, A.M., Wright, D., Militello, A., Akolekar, R. and Nicolaides, K.H. 2017. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 35-37 weeks' gestation. Ultrasound in Obstetrics and Gynecology. 50 (3), pp. 383-387. https://doi.org/10.1002/uog.17419
Chronic hypertension and adverse pregnancy outcome: a cohort study
Panaitescu, A.M., Syngelaki, A., Prodan, N., Akolekar, R. and Nicolaides, K.H. 2017. Chronic hypertension and adverse pregnancy outcome: a cohort study. Ultrasound in Obstetrics and Gynecology. 50 (2), pp. 228-235. https://doi.org/10.1002/uog.17493
Impaired placentation in women with chronic hypertension who develop pre-eclampsia
Panaitescu, A.M., Akolekar, R., Kametas, N., Syngelaki, A. and Nicolaides, K.H. 2017. Impaired placentation in women with chronic hypertension who develop pre-eclampsia. Ultrasound in Obstetrics and Gynecology. 50 (4), pp. 496-500. https://doi.org/10.1002/uog.17517
Association of chronic hypertension with birth of small-for-gestational-age neonate
Panaitescu, A.M., Baschat, A.A., Akolekar, R., Syngelaki, A. and Nicolaides, K.H. 2017. Association of chronic hypertension with birth of small-for-gestational-age neonate. Ultrasound in Obstetrics and Gynecology. 50 (3), pp. 361-366. https://doi.org/10.1002/uog.17553
Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia
Rolnik, D.L., Wright, D., Poon, L.C., O'Gorman, N., Syngelaki, A., de Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., Molina, F.S., Persico, N., Jani, J.C., Plasencia, W., Papaioannou, G., Tenenbaum-Gavish, K., Meiri, H., Gizurarson, S., Maclagan, K. and Nicolaides, K.H. 2017. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. The New England Journal of Medicine. 377 (7), pp. 613-622. https://doi.org/10.1056/NEJMoa1704559
Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history.
Poon, L.C., Wright, D., Rolnik, D.L., Syngelaki, A., Delgado, J.L., Tsokaki, T., Leipold, G., Akolekar, R., Shearing, S., De Stefani, L., Jani, J.C., Plasencia, W., Evangelinakis, N., Gonzalez-Vanegas, O., Persico, N., Nicolaides, K.H. and Allen, A. 2017. Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. American Journal of Obstetrics & Gynecology. 217 (5), pp. 585.e1- 5.. https://doi.org/10.1016/j.ajog.2017.07.038
Association between insulin resistance and preeclampsia in obese non-diabetic women receiving metformin
Balani, J., Hyer, S., Syngelaki, A., Akolekar, R., Nicolaides, K. H., Johnson, A. and Shehata, H. 2017. Association between insulin resistance and preeclampsia in obese non-diabetic women receiving metformin. Obstetric Medicine. 10, pp. 170-173. https://doi.org/10.1177/1753495X17725465